Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 11Rituximab 9fludarabine phosphate 7fludarabine 4Whole-Body Irradiation 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Alemtuzumab 4Tacrolimus 3Prednisone 3Melphalan 3Cytogenetic Analysis 3Busulfan 3Vincristine 2Pentostatin 2Patient Reported Outcome Measures 2Mesna 2In Situ Hybridization, Fluorescence 2Gene Expression Profiling 2Flow Cytometry 2Filgrastim 2Doxorubicin 2Bendamustine Hydrochloride 2ruxolitinib 1plerixafor 1pegfilgrastim 1merphos 1liposomal amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Lymphocytic, Chronic, B-Cell × bismuth tripotassium dicitrate × Clear all
NCT00003151 2012-07-02

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
96 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡